Sobre Nosotros

The General and Digestive Surgery Department of Madrid Norte Hospital, is integrated in the structure of the Grupo Hospital de Madrid (GHM).

Therefore our work is guided by a definite innovative nature and aims for the excellence in medical quality.

This Service began in 1999 in Madrid Montepríncipe Hospital, where our portfolio of services increased gradually. The headship of the GHM and the working environment have permitted the professional development of the members of the group.

This new hospital consolidates GHM's philosophy, as we offer and guarantee a comprehensive assistance to our patients (specially those with cancer) thanks to the advantages that a general hospital gives. Therefore, it is one more step in the variety of high-quality services that the Grupo carries out.

Today, a perfect scenario for medical education is possible thanks to the new Research and Innovation Deparment, the creation of the Tumor Tissue Bank and the consolidation of the working units. This completes the three-sided working scope that governs the activity of this Surgery Department.

CIOCC

Clara Campal Comprehensive Cancer Center

The center is annexed to HM University Sanchinarro, is the culmination of the project that Dr. Juan Abarca Campal started nearly 20 years ago creating the HM Hospitales, and in which three other hospitals (HM Universitario Madrid, HM Universitario Montepríncipe and HM Universitario Torrelodones) and five polyclinics in the Community of Madrid.

Events

M T W T F S S
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31
 
 

Novedades

22-09-2020

G3NETs and NECs have similar postoperative survival; surgery for high grade PNETs should therefore be considered judiciously. Outcomes from G1/G2 lesions in this series were also similar, but further prospective work is necessary to investigate whether or not in resecting PNETs that G1 and G2 lesions should be dealt with in the same manner.

This represents the first international, pancreas-specific evaluation of the WHO 2017 guidelines. The presented findings may help inform surgical strategies for the optimal management of these rare instances of a rare disease.

06-09-2020

Actual survival prognostic factors for resected R0 pancreatic cancer are not yet clearly defined. Furthermore, most of the papers focused on this topic are referred to actuarial survival (estimated but not real).

23-09-2020

An eco-doppler or electromagnetic flowmeter measurements are the only effective procedures in radical pancreatic cancer surgery with arterial resection associated.

This technique determines the speed and volume of the reconstructed arterial or venous vessel flow, allowing the reduction of ischemic complications often associated to high morbidity and mortality.

Eventos

M T W T F S S
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31
 
 

Twitter

No front page content has been created yet.

 
Health Teaching
General Interest Areas
Professional Area